Lv1
90 积分 2022-01-29 加入
Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
1天前
已完结
A Phase 1 study of the anti-tissue factor antibody-drug conjugate XB002 in patients with advanced solid tumors (JEWEL-101): initial results from the dose-escalation stage
1天前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
5个月前
已完结
New ADCs bring new questions in EGFR NSCLC and beyond
9个月前
已完结
PI3K inhibitors are finally coming of age
1年前
已完结
Preclinical Development of Antibody–Drug Conjugates
1年前
已完结
The story of EGFR: from signaling pathways to a potent anticancer target
1年前
已完结
Bioanalytical strategy for the characterization and bioanalysis of biologics: a global, nonregulated bioanalytical lab perspective
1年前
已完结
Development and validation of a hybrid immunoaffinity LC–MS/MS assay for quantitation of total antibody (TAb) from an antibody drug conjugate (ADC) PYX-201 in human plasma
1年前
已完结
Sym004 anti-EGFR antibody mixture overcomes resistance to anti-EGFR antibodies in metastatic colorectal cancer
1年前
已完结
皖公网安备34019202002308
